Skip to content

Outcomes of blended vision created by laser using special software in patients having near vision difficulty

Clinical outcomes and patient satisfaction following Laser Blended Vision for presbyopia correction using MeL 90 platform - LBV

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/09/005011
Enrollment
50
Registered
2014-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- healthy individuals in presbyopic age group

Interventions

Intervention1: micromonovision using Mel 90: Dominant eye will be corrected for distance and non dominant eye corrected for near by keeping an anisometropia of -1.50 D, using the Mel-90 Laser platform

Sponsors

Research Foundation Nethradhama Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects medically suitable for LASIK, 2. Presbyopic with corrected distant visual acuity(CDVA) no worse than 20/25 in either eye 3. Tolerance of at least -0.75 D anisometropia 4. Myopic patients with spherical equivalent (SE) refraction -8.50 D in both eyes 5. Hyperopic patients with SE upto +5.75 D in both eyes 6. Willing to accept a slight difference in vision between both eyes 8. Willing to use prescription corrective lenses to enhance vision to do precision tasks(reading small prints, needlework) 7. Soft contact lens discontinued for minimum 1 week and Rigid Gas Permeable contact lens discontinued for minimum 3 week 8.Ability to understand and willingness to sign informed consent and participate in follow up visits

Exclusion criteria

Exclusion criteria: 1.Eyes with dense amblyopia with BSCVA 2.Evidence of ocular diseases like severe meibomian gland diseases, herpetic keratitis, uvietis, glaucoma. 3.Visually significant cataract, retinal diseases like retinal dystrophies or diabetic retinopathy. 4.Corneal pathologies like corneal dystrophies , keratoconus, H/o corneal trauma or surgery within flap zone 5.Dry eye status-Schirmer’s I value less than 10 mm 6.Long term ocular medication like ß blockers. 7. Patients on systemic medication likely to affect wound healing like corticosteroids or antimetabolites. 8.H/o immunocompromised state or pregnancy or nursing mothers . 9.Patients with unrealistic expectations.

Design outcomes

Primary

MeasureTime frame
improvement in uncorrected distance, intermediate and near visionTimepoint: day 1, day 15,3 months, and 6 months

Secondary

MeasureTime frame
aberrations, topography, contrast sensitivityTimepoint: day 15, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Sri Ganesh

Nethradhama Superspeciality Eye Hospital

brar_sheetal@yahoo.co.in9591002092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026